- Yokohama-shi Top Page
- Health, Medical Care and Welfare
- Health and Medical Care
- Vaccinations infectious disease
- Infectious diseases
- About Ebola hemorrhagic fever and Middle East Respiratory Syndrome (MERS)
Here's the text.
About Ebola hemorrhagic fever and Middle East Respiratory Syndrome (MERS)
Last Updated March 28, 2024
What is Ebola hemorrhagic fever?
Causes | Ebolavirus |
---|---|
Path of infection | When the patient touches the body fluids (blood, secretions, vomit / excrement) of a patient whose symptoms are manifested without sufficient protection, the virus invades through wounds and mucous membranes and becomes infected. In endemic areas, wildlife can also be transmitted from wild animals. Generally, it is not transmitted from asymptomatic patients and there is no airborne infection. |
Occurrence area | Guinea, Sierra Leone, Liberia, Uganda, Sudan, Gabon, Cote d'Ivoire, Democratic Republic of Congo, Republic of the Congo, Republic of the Congo |
Symptoms | After an incubation period of 2 to 21 days (usually 7 to 10 days), symptoms such as sudden fever, headache, malaise, muscle pain, and sore throat appear. |
Prevention and | Currently, there are no vaccines or specific treatment. Symptomatic treatment is given according to the patient's symptoms. |
- Since March 2014, major outbreaks have occurred in Guinea, Liberia, Sierra Leone, Mali and Nigeria in western Africa.
What is Middle East Respiratory Syndrome (MERS)?
Causes | MERS coronavirus (confirmed for the first time in 2012) |
---|---|
Path of infection | How humans become infected is still unclear exactly. Dromedary camels are said to be a type of animal infected with the MERS virus, but many patients have no history of contact with animals. Infections have also been reported between close contacts, such as between families, between patients in medical institutions with inadequate infection control measures, and between patients and healthcare professionals. |
Occurrence area | United Arab Emirates, Yemen, Oman, Qatar, Kuwait, Saudi Arabia, Jordan |
Symptoms | After an incubation period of about 2 to 14 days, most patients will develop pneumonia due to fever and acute severe respiratory symptoms. Some patients may be mildly ill or atypical findings. |
Prevention and | Currently, there are no vaccines or specific treatment. Symptomatic treatment is given according to the patient's symptoms. |
To the citizens
If it is unavoidable to travel to the affected area, use the "Country / Region Information" (external site) of the Ministry of Health, Labour and Welfare Quarantine Station FORTH and "Overseas Safety Information" (external site) of the Ministry of Foreign Affairs' "Overseas Safety Information" (external site). Check the situation, consider whether or not to travel, and make sure to take basic hygiene measures (hand washing, avoid contact with patients and animals, avoid contact with patients and animals, etc.)
If you experience symptoms after traveling to the affected area or contact with an infected person, do not consult a medical institution directly. Please call the Health and Welfare Center Health and Welfare Division Health Promotion Section in each ward.
※Please contact the Yokohama City Public Health Center Infectious Disease Food Poisoning Emergency Call Dial in case of emergency in case of any of the above during weekday business hours. Please refrain from contacting us if there is no urgency for emergency use during night holidays.
To Medical Institutions
If you have any suspected cases that meet the notification criteria, please contact the following Phone number immediately.
■Notification criteria
・Ebola hemorrhagic fever (outside site)
・Middle East Respiratory Syndrome (outside site)
■Phone number
(Weekdays from 8:30 to 17:15) Health and Welfare Division Health Promotion Section, Health and Welfare Center
(In case of emergency outside of the above hours) Yokohama City Public Health Center infectious disease food poisoning emergency call dial
■Notifications to medical institutions
- "Response Assuming domestic outbreak of Ebola and Middle East Respiratory Syndrome (MERS)" (PDF: 429KB)September 25, 2015
- About correspondence at the time of domestic outbreak of Middle East Respiratory Syndrome (MERS) (Notice) (PDF: 657KB) (PDF: 657KB)(As of June 12, 2015)
- About outbreak of Middle East Respiratory Syndrome (MERS) in Korea (Notice) (PDF: 688KB) (PDF: 688KB)(As of June 5, 2015)
- About correspondence to Middle East Respiratory Syndrome (MERS) in Korea (Notice) (PDF: 637KB) (PDF: 637KB)(As of June 3, 2015)
Related Sites
Ebola hemorrhagic fever
- About Ebola hemorrhagic fever (outside site)(Ministry of Health, Labour and Welfare)
- Ebola virus disease (Ebola virus disease) (external site)(Ministry of Health, Labour and Welfare Quarantine Station FORTH)
- What is Ebola hemorrhagic fever (outside site)(National Institute of Infectious Diseases)
- Ebola virus disease (external site)(WHO)
- Ebola (Ebola Virus Disease) (external site)(CDC)
Middle East Respiratory Syndrome (MERS)
- About Middle East Respiratory Syndrome (MERS) (outside site)(Ministry of Health, Labour and Welfare)
- Middle East respiratory syndrome (Middle East Respiratory Syndrome: MERS) (external site)(Ministry of Health, Labour and Welfare Quarantine Station FORTH)
- MERS (outside site)(National Institute of Infectious Diseases)
- Outbreak of infectious diseases caused by MERS coronavirus (outside site)(Ministry of Foreign Affairs Overseas Safety Website)
In order to open PDF files, you may need a separate PDF reader.
If you do not have it, you can download it free of charge from Adobe.
To download Adobe Acrobat Reader DC
For inquiries to this page
Health and Safety Division, Medical Care Bureau Health and Safety Department
Phone: 045-671-2463
Phone: 045-671-2463
Fax: 045-664-7296
Email address: ir-kenkoanzen@city.yokohama.jp
Page ID: 592-378-795